Optic IconOptic Logo
|
SearchCollectionsBenchmarks
Product

IMC-001

Aliases
Not confirm yet

2 clinical trials

4 indications

Indication
Extranodal NK/T-cell Lymphoma
Indication
Nasal Type
Indication
Tumor mutational burden-high
Indication
Metastatic or Locally Advanced Solid Tumors
Clinical trial
An Open-label, Single-arm, Phase 2 Study to Investigate the Efficacy and Safety of IMC-001 in Patients With Relapsed or Refractory Extranodal NK/T Cell Lymphoma, Nasal Type
Status: Active (not recruiting), Estimated PCD: 2024-07-30
Clinical trial
PHASE 2 STUDY OF IMC-001 IN PATIENTS WITH METASTATIC OR LOCALLY ADVANCED TMB-H SOLID TUMOR
Status: Not yet recruiting, Estimated PCD: 2025-12-01